Cue Biopharma, Inc. (CUE) Capital expenditures 2017–2025
Cue Biopharma, Inc. (CUE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$177,000FY2025 · since FY2017: $1.0M → $177,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $177,000 | +168.2% |
| FY2024 | $66,000 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $171,000 | -81.3% |
| FY2021 | $913,039 | +53.4% |
| FY2020 | $595,259 | +1184.2% |
| FY2019 | $46,353 | -97.5% |
| FY2018 | $1.9M | +80.0% |
| FY2017 | $1.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice